Abnormal metabolic networks in atypical parkinsonism

Movement Disorders

Volumn 23, Issue 5, 2008, Pages 727-733

  Eckert, Thomas ^a,b   Tang, Chengke ^b   Ma, Yilong ^b,c   Brown, Nathaniel ^b   Lin, Tanya ^b,d   Frucht, Steven ^e   Feigin, Andrew ^b,c   Eidelberg, David ^b,c  

^a OTTO VON GUERICKE UNIVERSITY   (Germany)

^b FEINSTEIN INSTITUTE FOR MEDICAL RESEARCH   (United States)

^c NEW YORK UNIVERSITY SCHOOL OF MEDICINE   (United States)

^d ALBERT EINSTEIN COLLEGE OF MEDICINE   (United States)

^e NEUROLOGICAL INSTITUTE   (United States)

Author keywords

Atypical parkinsonism; FDG PET; Metabolic network; Multiple system atrophy; Progressive supranuclear palsy

Indexed keywords

BIOLOGICAL MARKER; FLUORODEOXYGLUCOSE F 18; DIAGNOSTIC AGENT;

ADULT; AGED; ARTICLE; ATYPICAL PARKINSONISM; BRAIN FUNCTION; BRAIN METABOLISM; CONTROLLED STUDY; DIAGNOSTIC ACCURACY; DISEASE ASSOCIATION; EVOKED BRAIN STEM RESPONSE; FEMALE; FRONTAL CORTEX; HUMAN; IMAGE ANALYSIS; MAJOR CLINICAL STUDY; MALE; PARKINSONISM; PATHOGENESIS; PATTERN RECOGNITION; POSITRON EMISSION TOMOGRAPHY; PRIORITY JOURNAL; PROGRESSIVE SUPRANUCLEAR PALSY; QUANTITATIVE ANALYSIS; SENSITIVITY AND SPECIFICITY; SHY DRAGER SYNDROME; BRAIN STEM; CEREBELLUM; COHORT ANALYSIS; DIFFERENTIAL DIAGNOSIS; FRONTAL LOBE; METABOLISM; MIDDLE AGED; NERVE CELL NETWORK; PUTAMEN; REFERENCE VALUE; REPRODUCIBILITY; SCINTISCANNING;

AGED; BRAIN STEM; CEREBELLUM; COHORT STUDIES; DIAGNOSIS, DIFFERENTIAL; FEMALE; FLUORODEOXYGLUCOSE F18; FRONTAL LOBE; HUMANS; MALE; MIDDLE AGED; MULTIPLE SYSTEM ATROPHY; NERVE NET; PARKINSONIAN DISORDERS; POSITRON-EMISSION TOMOGRAPHY; PUTAMEN; REFERENCE VALUES; REPRODUCIBILITY OF RESULTS; SUPRANUCLEAR PALSY, PROGRESSIVE;

EID: 44449121269     PISSN: 08853185     EISSN: 15318257     Source Type: Journal    
DOI: 10.1002/mds.21933     Document Type: Article

References (37)

1. Moghal S, Rajput AH, D'Arcy C, Rajput R. Prevalence of movement disorders in elderly community residents. Neuroepidemiology 1994;13:175-178.
2. Hughes AJ, Daniel SE, Kilford L, Lees AJ. Accuracy of clinical diagnosis of idiopathic Parkinson's disease: a clinico-pathological study of 100 cases. J Neurol Neurosurg Psychiatry 1992;55:181-184.
3. Schrag A, Ben-Shlomo Y, Quinn NP. Prevalence of progressive supranuclear palsy and multiple system atrophy: a cross-sectional study. Lancet 1999;354:1771-1775.
4. Hughes AJ, Daniel SE, Ben-Shlomo Y, Lees AJ. The accuracy of diagnosis of parkinsonian syndromes in a specialist movement disorder service. Brain 2002;125 (Part 4):861-870.
5. Seppi K, Schocke MF, Esterhammer R, et al. Diffusion-weighted imaging discriminates progressive supranuclear palsy from PD, but not from the parkinson variant of multiple system atrophy. Neurology 2003;60:922-927.
6. Eckert T, Sailer M, Kaufmann J, et al. Differentiation of idiopathic Parkinson's disease, multiple system atrophy, progressive supranuclear palsy, and healthy controls using magnetization transfer imaging. Neuroimage 2004;21:229-235.
7. Eckert T, Eidelberg D. The role of functional neuroimaging in the differential diagnosis of idiopathic Parkinson's disease and multiple system atrophy. Clin Auton Res 2004;14:84-91.
8. Eckert T, Barnes A, Dhawan V, et al. FDG PET in the differential diagnosis of parkinsonian disorders. Neuroimage 2005;26:912-921.
9. Piccini P, Brooks DJ. New developments of brain imaging for Parkinson's disease and related disorders. Mov Disord 2006;21: 2035-2041.
10. Scherfler C, Seppi K, Donnemiller E, et al. Voxel-wise analysis of [123I]beta-CIT SPECT differentiates the Parkinson variant of multiple system atrophy from idiopathic Parkinson's disease. Brain 2005;128 (Part 7):1605-1612.
11. Seppi K, Scherfler C, Donnemiller E, et al. Topography of dopamine transporter availability in progressive supranuclear palsy: a voxelwise [123I]beta-CIT SPECT analysis. Arch Neurol 2006;63: 1154-1160.
12. Spetsieris P, Ma Y, Dhawan V, Moeller JR, Eidelberg D. Highly automated computer-aided diagnosis of neurological disorders using functional brain imaging. Proc SPIE: Med Imag 2006;6144: 61445M1-12.
13. Ma Y, Tang C, Spetsieres P, Dhawan V, Eidelberg D. Abnormal metabolic network activity in Parkinson's disease: test-retest reproducibility. J Cereb Blood Flow Metab 2007;27:597-605.
14. Eckert T, Van Laere K, Tang C, et al. Quantification of PD-related network expression with ECD SPECT. Eur J Nucl Med Mol Imag 2007;34:496-501.
15. Eckert T, Feigin A, Lewis DE, Dhawan V, Frucht S. Regional metabolic changes in parkinsonian patients with normal dopaminergic imaging. Mov Disord 2007;22:167-173.
16. Asanuma K, Tang C, Ma Y, et al. Network modulation in the treatment of Parkinson's disease. Brain 2006;129 (Part 10):2667-2678.
17. Huang C, Tang C, Feigin A, et al. Changes in network activity with the progression of Parkinson's disease. Brain 2007;130 (Part 7): 1834-1846.
18. Litvan I, Agid Y, Calne D, et al. Clinical research criteria for the diagnosis of progressive supranuclear palsy (Steele-Richardson-Olszewski syndrome): report of the NINDS-SPSP international workshop. Neurology 1996;47:1-9.
19. Litvan I, Booth V, Wenning GK, et al. Retrospective application of a set of clinical diagnostic criteria for the diagnosis of multiple system atrophy. J Neural Transm 1998;105(2-3):217-227.
20. Moeller JR, Ishikawa T, Dhawan V, et al. The metabolic topography of normal aging. J Cereb Blood Flow Metab 1996;16:385-398.
21. Gusnard DA, Raichle ME. Searching for a baseline: functional imaging and the resting human brain. Nat Rev Neurosci 2001;2: 685-694.
22. Burnham KP, Anderson DR. Model selection and multimodel inference: a practical information-theoretic approach, 2nd ed. New York: Springer-Verlag; 2002.
23. Scarmeas N, Habeck CG, Zarahn E, et al. Covariance PET patterns in early Alzheimer's disease and subjects with cognitive impairment but no dementia: utility in group discrimination and correlations with functional performance. NeuroImage 2004;23:35-45.
24. Moeller JR, Nakamura T, Mentis MJ, et al. Reproducibility of regional metabolic covariance patterns: comparison of four populations. J Nucl Med 1999;40:1264-1269.
25. Efron B, Tibshirani R. An introduction to the bootstrap. New York: CRC Press; 1994.
26. Eidelberg D, Takikawa S, Moeller JR, et al. Striatal hypometabolism distinguishes striatonigral degeneration from Parkinson's disease. Ann Neurol 1993;33:518-527.
27. Otsuka M, Ichiya Y, Kuwabara Y, et al. Glucose metabolism in the cortical and subcortical brain structures in multiple system atrophy and Parkinson's disease: a positron emission tomographic study. J Neurol Sci 1996;144(1-2):77-83.
28. Antonini A, Kazumata K, Feigin A, et al. Differential diagnosis of parkinsonism with [18F]fluorodeoxyglucose and PET. Mov Disord 1998;13:268-274.
29. Ghaemi M, Hilker R, Rudolf J, Sobesky J, Heiss WD. Differentiating multiple system atrophy from Parkinson's disease: contribution of striatal and midbrain MRI volumetry and multi-tracer PET imaging. J Neurol Neurosurg Psychiatry 2002;73:517-523.
30. Taniwaki T, Nakagawa M, Yamada T, et al. Cerebral metabolic changes in early multiple system atrophy: a PET study. J Neurol Sci 2002;200(1-2):79-84.
31. Davie CA, Wenning GK, Barker GJ, et al. Differentiation of multiple system atrophy from idiopathic Parkinson's disease using proton magnetic resonance spectroscopy. Ann Neurol 1995;37: 204-210.
32. Schrag A, Good CD, Miszkiel K, et al. Differentiation of atypical parkinsonian syndromes with routine MRI. Neurology 2000;54: 697-702.
33. Van Laere K, Santens P, Bosman T, De Reuck J, Mortelmans L, Dierckx R. Statistical parametric mapping of (99m)Tc-ECD SPECT in idiopathic Parkinson's disease and multiple system atrophy with predominant parkinsonian features: correlation with clinical parameters. J Nucl Med 2004;45:933-942.
34. Foster NL, Gilman S, Berent S, Morin EM, Brown MB, Koeppe RA. Cerebral hypometabolism in progressive supranuclear palsy studied with positron emission tomography. Ann Neurol 1988;24: 399-406.
35. Blin J, Baron JC, Dubois B, et al. Positron emission tomography study in progressive supranuclear palsy. Brain hypometabolic pattern and clinicometabolic correlations. Arch Neurol 1990;47:747-752.
36. Hauw JJ, Daniel SE, Dickson D, et al. Preliminary NINDS neuropathologic criteria for Steele-Richardson-Olszewski syndrome (progressive supranuclear palsy). Neurology 1994;44:2015-2019.
37. Paviour DC, Price SL, Jahanshahi M, Lees AJ, Fox NC. Regional brain volumes distinguish PSP, MSA-P, and PD: MRI-based clinico-radiological correlations. Mov Disord 2006;21:989-996.